The most important financial indicators for the company Hexy Vet Pharma S.r.l. - Unique Identification Number 46284164:
sales in 2023 was
121.111
euro, registering a net profit of
14.024
euro and having an average number of
3
employees.
Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al produselor farmaceutice, in magazine specializate having the NACE code 4773.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 1,326.4%, from 8.516 euro in the year 2022, to 121.111 euro in 2023.
The Net Profit decreased by -8.828 euro, from 22.921 euro in 2022, to 14.024 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Hexy Vet Pharma S.r.l. - CUI 46284164
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
-
-
-
-
-
-
-
-
18.277
16.015
Current Assets
-
-
-
-
-
-
-
-
28.999
30.555
Inventories
-
-
-
-
-
-
-
-
6.229
26.017
Receivables
-
-
-
-
-
-
-
-
14.763
-1.358
Cash
-
-
-
-
-
-
-
-
8.007
5.896
Shareholders Funds
-
-
-
-
-
-
-
-
23.124
37.078
Social Capital
-
-
-
-
-
-
-
-
203
202
Debts
-
-
-
-
-
-
-
-
10.559
9.492
Income in Advance
-
-
-
-
-
-
-
-
13.593
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
30.555 euro in 2023 which includes Inventories of
26.017 euro, Receivables of
-1.358 euro and cash availability of
5.896 euro.
The company's Equity was valued at
37.078 euro, while total Liabilities amounted to
9.492 euro.
Equity increased by 14.024 euro, from 23.124 euro in 2022, to 37.078 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Hexy Vet Pharma S.r.l.